Annh Vo

Biopharmaceutical Characterization and Oral Efficacy of a New Rapid Acting Antidepressant Ro 25-6981.

D. B. Rawlins, V. Yellepeddi, David B Rawlins, 2018, Journal of pharmaceutical sciences.

A Phase II Study of Pembrolizumab in Combination with Romidepsin Demonstrates Durable Responses in Relapsed or Refractory T-Cell Lymphoma (TCL)

Michael L. Wang, C. Flowers, S. Parmar, 2020 .